Xpert CT

Untreated Chlamydia trachomatis infections can lead to serious complications including pelvic inflammatory disease (PID), where the majority of symptoms are too mild or nonspecific women to seek medical treatment. Of those women with PID, 20% will become infertile; 18% will experience debilitating, chronic pelvic pain; and 9% will have a life-threatening tubal pregnancy. (CDC MMWR, Vol. 51 / No. RR-15)

Runs On: GeneXpert^® System

 

The Need

According to the World Health Organization (2001), an estimated 92 million chlamydia infections occurred worldwide, affecting more than 50 million women and 42 million men. 

Young people under 25 years of age carry the burden of up to 50% of CT/NG infections in a population.  Infections left undiagnosed and treated impact patient health, fertility, and increase vulnerability to other opportunistic infections such as HPV and HIV.

The Solution

Xpert^® CT

• Specific detection of Chlamydia trachomatis (CT)
• Easy to use for near patient testing clinical environments
• Sample adequacy and Process controls for every sample tested
• Results in 90 minutes; requires no instrumentation other than the GeneXpert^® System
• On-demand results enable physicians to consult and treat patients with the appropriate medications

* Not available in all regions.